In C1QTNF6−/− mice, C1QTNF6 was demonstrated to serve as a novel regulator of the complement alternative pathway with potential to treat rheumatoid arthritis in clinical studies [15]. Here, C1QTNF6 is linked to rheumatoid arthritis.